Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, Booker L, Yazdi H.

Evid Rep Technol Assess (Summ). 2005 Aug;(128):1-11. Review. No abstract available.

2.

[IFG and IGT in Europe and America: the present and prospective].

Tsujii S, Kuzuya H.

Nihon Rinsho. 2005 Feb;63 Suppl 2:27-33. Review. Japanese. No abstract available.

PMID:
15779341
3.

[Effect of impaired fasting glucose and impaired glucose tolerance on the progression of diabetic macroangiopathy].

Igarashi M, Tominaga M.

Nihon Rinsho. 2005 Feb;63 Suppl 2:55-60. Review. Japanese. No abstract available.

PMID:
15779345
4.

[Primary prevention of diabetes--importance of early diagnosis and interventions in IGT & IFG].

Kawamori R.

Nihon Rinsho. 2005 Feb;63 Suppl 2:49-54. Review. Japanese. No abstract available.

PMID:
15779344
5.

[Treatment for patients with impaired glucose tolerance].

Tawaramoto K, Kaku K.

Nihon Rinsho. 2005 Feb;63 Suppl 2:423-7. Review. Japanese. No abstract available.

PMID:
15779416
6.

[Borderline type, impaired glucose tolerance (IGT), and impaired fasting glucose (IFG): their concepts, classification and significance].

Kuzuya T.

Nihon Rinsho. 2005 Feb;63 Suppl 2:15-20. Review. Japanese. No abstract available.

PMID:
15779339
7.

How to assess for impaired glucose tolerance before transplantation and should these results influence the choice of calcineurin inhibitors?

Filler G, Hadjiyannakis S.

Pediatr Transplant. 2006 Feb;10(1):1-4. No abstract available.

PMID:
16499579
8.
9.

Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.

Sanusi H.

Acta Med Indones. 2004 Jan-Mar;36(1):36-41. Review.

10.

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.

Krum H, McMurray JJ, Horton E, Gerlock T, Holzhauer B, Zuurman L, Haffner SM, Bethel MA, Holman RR, Califf RM.

Cardiovasc Ther. 2010 Apr;28(2):124-32. doi: 10.1111/j.1755-5922.2010.00146.x. Epub 2010 Feb 23.

PMID:
20184589
11.

[Insulin secretion and insulin sensitivity in subjects with impaired fasting glucose].

Nishi Y, Yamada Y, Fukushima M, Seino Y.

Nihon Rinsho. 2005 Feb;63 Suppl 2:151-4. Review. Japanese. No abstract available.

PMID:
15779360
12.

Definition of prediabetes.

Buysschaert M, Bergman M.

Med Clin North Am. 2011 Mar;95(2):289-97, vii. doi: 10.1016/j.mcna.2010.11.002. Review.

PMID:
21281833
13.

Impaired glucose tolerance and impaired fasting glucose.

Rao SS, Disraeli P, McGregor T.

Am Fam Physician. 2004 Apr 15;69(8):1961-8.

14.

Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).

Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE.

Circulation. 2007 Jul 10;116(2):151-7. Epub 2007 Jun 18.

15.

The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk.

Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B.

J Clin Endocrinol Metab. 2010 Sep;95(9):4345-53. doi: 10.1210/jc.2010-0361. Epub 2010 Jul 14.

PMID:
20631030
16.

[Clinical and metabolic features of subjects with glucose intolerance and high fasting glucose levels].

Arteaga Llona A, Pollak F, Robres L, Velasco N.

Rev Med Chil. 2009 Feb;137(2):193-9. doi: /S0034-98872009000200002. Epub 2009 Jun 10. Spanish.

17.

Detecting diabetes and impaired glucose tolerance in patients with atherosclerotic peripheral arterial disease.

Green FC, Levison R, Newton DJ, Littleford R, Stonebridge PA, Belch JJ.

Int Angiol. 2012 Apr;31(2):125-8.

PMID:
22466976
18.
19.

[Abnormal glycemic metabolism in essential hypertension. Role of the an oral glucose tolerance test].

Stiefel P, Miranda ML, Muñiz O, Nieto MD, Jiménez L, Villar J.

Med Clin (Barc). 2005 Jul 2;125(5):179-81. Spanish.

PMID:
16153358
20.

Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.

Deedwania PC, Fonseca VA.

Am J Med. 2005 Sep;118(9):939-47. Review.

PMID:
16164876

Supplemental Content

Support Center